Treatment of genital warts with Interferon alpha-2b Cream: a randomized, double blind, placebo-controlled study
- Conditions
- Condylomata acuminata (genital warts)MedDRA version: 9.1Level: LLTClassification code 10059313Term: Anogenital warts
- Registration Number
- EUCTR2005-000162-40-DE
- Lead Sponsor
- Helix Product Development (Ireland) Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Female patients, 18 years of age or older
Clinical diagnosis of condylomata acuminata with HPV status confirmation
2 - 20 external genital warts with maximum of 1 year history
Otherwise normal anogenital skin
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Pregnant or lactating females
Cervical dysplasia
HIV or other STI
Transplant patients, Autoimmune diseases, Rheumatoid Arthritis, Diabetes
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method